Ametek (AME – Research Report), the Industrials sector company, was revisited by a Wall Street analyst yesterday. Analyst Andrew Obin from Bank of America Securities reiterated a Buy rating on the stock and has a $225.00 price target.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Andrew Obin has given his Buy rating due to a combination of factors including a cyclical upturn, successful merger synergies, and the conclusion of the destocking drag. Despite a challenging comparison, Ametek’s organic orders increased by 4% year-over-year, with Paragon Medical showing a significant sequential rise in orders. Although the initial 2025 adjusted EPS guidance was lower than the previous consensus, Obin believes management is wisely setting conservative expectations as the year begins.
Additionally, Ametek’s recent acquisition of Kern Microtechnik and the positive trend in the U.S. Manufacturing Purchasing Manager’s Index bolster confidence in the company’s growth prospects. These elements, combined with Ametek’s strong capital allocation and operational execution, justify a price objective of $225, which is slightly above the peer average multiple. Obin’s forecast for Ametek’s 2025 adjusted EPS aligns well with broader industry trends, reinforcing the Buy recommendation.
According to TipRanks, Obin is a 5-star analyst with an average return of 13.9% and a 64.05% success rate. Obin covers the Industrials sector, focusing on stocks such as Ametek, Eaton, and Honeywell International.